We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$441M
AUM Growth
+$91.2M
(+26%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
16.9%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$15.4M |
| 2 |
Stellantis
STLA
|
+$9.9M |
| 3 |
Alcon
ALC
|
+$7.77M |
| 4 |
Amazon
AMZN
|
+$6.64M |
| 5 |
Ferrari
RACE
|
+$5.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Taiwan ETF
EWT
|
+$8.02M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$6.88M |
| 3 |
Linde
LIN
|
+$5.74M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$5.13M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.26% |
| 2 | Technology | 13.6% |
| 3 | Financials | 12.86% |
| 4 | Healthcare | 10.91% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Vitamin Cottage Natural Grocers
NGVC
$729M
| $113K | 0.03% |
+10,493
| New | +$142K |
|
|
CONE
527
DELISTED
CyrusOne Inc Common Stock
CONE
| $112K | 0.03% |
1,529
-81
| -5% | -$5.9K |
|
528
Carnival Corporation Ltd
CCL
$37.1B
| $112K | 0.03% |
4,895
| – | – |
|
529
Alaunos Therapeutics
TCRT
$4.71M
| $109K | 0.02% |
302
| – | – |
|
530
HP
HPQ
$24.3B
| $105K | 0.02% |
3,713
-11,891
| -76% | -$380K |
|
531
Nuveen Credit Strategies Income Fund
JQC
$702M
| $103K | 0.02% |
15,500
| – | – |
|
|
URG
532
Ur-Energy
URG
$489M
| $102K | 0.02% |
83,469
-42,057
| -34% | -$57.5K |
|
|
PARAA
533
DELISTED
Paramount Global Class A
PARAA
| $100K | 0.02% |
2,200
| – | – |
|
534
Rhythm Pharmaceuticals
RYTM
$7.28B
| $100K | 0.02% |
5,167
| – | – |
|
535
Bumble
BMBL
$386M
| $100K | 0.02% |
1,922
+89
| +5% | +$4.7K |
|
536
Bath & Body Works
BBWI
$4.13B
| $99.8K | 0.02% |
+1,665
| New | +$90K |
|
537
Workhorse Group
WKHS
$30.2M
| $98.1K | 0.02% |
3
| – | – |
|
538
Digital Turbine
APPS
$1.04B
| $97.5K | 0.02% |
1,508
-21
| -1% | -$1.5K |
|
539
Phathom Pharmaceuticals
PHAT
$953M
| $96.6K | 0.02% |
2,837
+871
| +44% | +$31.2K |
|
540
Whirlpool
WHR
$2.44B
| $95.4K | 0.02% |
436
+10
| +2% | +$2.33K |
|
541
Lowe's Companies
LOW
$119B
| $94.8K | 0.02% |
488
+19
| +4% | +$3.72K |
|
542
nCino
NCNO
$1.93B
| $94.6K | 0.02% |
1,500
| – | – |
|
543
Bunge Global
BG
$22.8B
| $93.7K | 0.02% |
1,228
-5,727
| -82% | -$483K |
|
544
Medtronic
MDT
$108B
| $93.6K | 0.02% |
735
-5,480
| -88% | -$688K |
|
545
SmartFinancial
SMBK
$877M
| $93.3K | 0.02% |
+3,904
| New | +$91.9K |
|
546
Atea Pharmaceuticals
AVIR
$386M
| $93.2K | 0.02% |
+4,190
| New | +$126K |
|
547
Paycom
PAYC
$7.05B
| $93K | 0.02% |
250
+100
| +67% | +$35.4K |
|
548
Palantir
PLTR
$315B
| $92.6K | 0.02% |
4,127
| – | – |
|
549
Pathward Financial
CASH
$1.82B
| $92.2K | 0.02% |
+1,852
| New | +$91.9K |
|
550
Celanese
CE
$4.87B
| $91.9K | 0.02% |
596
+42
| +8% | +$6.67K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2021 Portfolio in Review
As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.
- Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
- Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
- Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
- Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
- Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
- Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
- Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.
Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.